Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment.
作者信息
Francis Jasmine H, Habib Larissa A, Abramson David H
机构信息
Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, United States.
出版信息
Adv Ophthalmol Optom. 2017 Aug;2(1):177-195. doi: 10.1016/j.yaoo.2017.03.008.
Abstract
摘要
相似文献
1
Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment.视网膜母细胞瘤中的玻璃体疾病：临床发现与治疗
Adv Ophthalmol Optom. 2017 Aug;2(1):177-195. doi: 10.1016/j.yaoo.2017.03.008.
2
Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.视网膜母细胞瘤玻璃体内种子云雾（3 级）：眼动脉化疗联合或不联合玻璃体内及眶周化疗的疗效比较。
Ophthalmology. 2017 Oct;124(10):1548-1555. doi: 10.1016/j.ophtha.2017.04.010. Epub 2017 May 22.
3
INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.视网膜母细胞瘤活动性玻璃体种植的玻璃体内化疗：192次连续注射后的结果。2015年霍华德·纳quin讲座
Retina. 2016 Jun;36(6):1184-90. doi: 10.1097/IAE.0000000000000903.
4
Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.联合玻璃体内注射马法兰和拓扑替康治疗视网膜母细胞瘤难治性或复发性玻璃体内播散。
JAMA Ophthalmol. 2014 Aug;132(8):936-41. doi: 10.1001/jamaophthalmol.2014.414.
5
Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.玻璃体内化疗治疗视网膜母细胞瘤的疗效与毒性：四年经验
Ophthalmology. 2017 Apr;124(4):488-495. doi: 10.1016/j.ophtha.2016.12.015. Epub 2017 Jan 12.
6
Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.玻璃体注射美法仑联合静脉/动脉化疗治疗伴有玻璃体种植的视网膜母细胞瘤
Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):391-4. doi: 10.1007/s00417-015-3202-0. Epub 2015 Oct 29.
7
Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.眼内注射美法仑治疗持续性或复发性视网膜母细胞瘤玻璃体内播散：初步结果。
JAMA Ophthalmol. 2014 Mar;132(3):319-25. doi: 10.1001/jamaophthalmol.2013.7666.
8
Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.重新探讨视网膜母细胞瘤玻璃体疾病的眼内化疗：从禁止到有条件的适应证。
Br J Ophthalmol. 2012 Aug;96(8):1078-83. doi: 10.1136/bjophthalmol-2011-301450. Epub 2012 Jun 13.
9
Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.视网膜母细胞瘤患儿单次玻璃体腔注射标准低剂量美法仑后发生的弥漫性脉络膜视网膜萎缩：病例报告
BMC Ophthalmol. 2016 Mar 15;16:27. doi: 10.1186/s12886-016-0204-6.
10
The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.视网膜母细胞瘤中玻璃体种子的分类与玻璃体内注射美法仑的反应。
Ophthalmology. 2015 Jun;122(6):1173-9. doi: 10.1016/j.ophtha.2015.01.017. Epub 2015 Mar 18.
引用本文的文献
1
Intravitreal chemotherapy-induced cataract in retinoblastoma: challenges and outcome.眼内化疗引起的视网膜母细胞瘤白内障：挑战与结果。
BMJ Case Rep. 2022 Dec 19;15(12):e250617. doi: 10.1136/bcr-2022-250617.
2
ERG and OCT abnormalities in retinoblastoma after melphalan intravitreous injection.美法仑玻璃体内注射后视网膜母细胞瘤的视网膜电图和光学相干断层扫描异常
Arq Bras Oftalmol. 2022 Jul 15;87(1):0037. doi: 10.5935/0004-2749.2021-0037. eCollection 2022.
3
Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions.13q 缺失综合征患者采用超选择性化疗和其他癌症靶向干预治疗视网膜母细胞瘤。
Pediatr Blood Cancer. 2021 May;68(5):e28845. doi: 10.1002/pbc.28845. Epub 2020 Dec 23.
本文引用的文献
1
Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.晚期视网膜母细胞瘤眼部的眼动脉化学手术
Ophthalmic Genet. 2017 Jan-Feb;38(1):16-21. doi: 10.1080/13816810.2016.1244695. Epub 2017 Jan 17.
2
Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding.玻璃体内注射美法仑和拓扑替康治疗伴有玻璃体种植的视网膜母细胞瘤后的眼压变化
J Pediatr Ophthalmol Strabismus. 2017 May 1;54(3):185-190. doi: 10.3928/01913913-20161116-01. Epub 2017 Jan 17.
3
Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.玻璃体内化疗治疗视网膜母细胞瘤的疗效与毒性：四年经验
Ophthalmology. 2017 Apr;124(4):488-495. doi: 10.1016/j.ophtha.2016.12.015. Epub 2017 Jan 12.
4
Classification of Vitreous Seeds in Retinoblastoma: Correlations with Patient, Tumor, and Treatment Characteristics.视网膜母细胞瘤中玻璃体种子的分类：与患者、肿瘤及治疗特征的相关性
Ophthalmology. 2016 Jul;123(7):1601-5. doi: 10.1016/j.ophtha.2016.02.036. Epub 2016 Mar 27.
5
Cytopathological Evaluation of Ocular Surface and Needle Washings Following Intravitreal Melphalan Injections for Retinoblastoma.视网膜母细胞瘤玻璃体内注射美法仑后眼表及针吸物的细胞病理学评估
J Pediatr Ophthalmol Strabismus. 2016;53(2):96-98. doi: 10.3928/01913913-20160311-01. Epub 2016 Feb 4.
6
Anterior Ocular Toxicity of Intravitreous Melphalan for Retinoblastoma.玻璃体内注射美法仑治疗视网膜母细胞瘤的眼前段毒性
JAMA Ophthalmol. 2015 Dec;133(12):1459-63. doi: 10.1001/jamaophthalmol.2015.3119.
7
The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.视网膜母细胞瘤中玻璃体种子的分类与玻璃体内注射美法仑的反应。
Ophthalmology. 2015 Jun;122(6):1173-9. doi: 10.1016/j.ophtha.2015.01.017. Epub 2015 Mar 18.
8
Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013.视网膜母细胞瘤中种子的分类与管理。2013年8月24日于根特举行的埃尔斯沃思讲座
Ophthalmic Genet. 2014 Dec;35(4):193-207. doi: 10.3109/13816810.2014.973045. Epub 2014 Oct 16.
9
Risk factors for severe neutropenia following intra-arterial chemotherapy for intra-ocular retinoblastoma.眼内视网膜母细胞瘤动脉内化疗后严重中性粒细胞减少的危险因素。
PLoS One. 2014 Oct 10;9(10):e108692. doi: 10.1371/journal.pone.0108692. eCollection 2014.
10
Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.视网膜母细胞瘤玻璃体内注射美法仑后出现的玻璃体条索状瘤栓
JAMA Ophthalmol. 2014 Aug;132(8):1024-5. doi: 10.1001/jamaophthalmol.2014.436.
Zotero 插件